The role of natural products in the prevention and treatment of pulmonary fibrosis: a review

Pulmonary fibrosis is an incurable end-stage lung disease and remains a global public health problem. Although there have been some breakthroughs in understanding the pathogenesis of pulmonary fibrosis, effective intervention methods are still limited. Natural products have the advantages of multiple biological activities and high levels of safety, which are important factors for preventing and treating pulmonary fibrosis. In this review, we summarized the mechanisms and health benefits of natural products against pulmonary fibrosis. These natural products target oxidative stress, inflammatory injury, epithelial-mesenchymal transition (EMT), fibroblast activation, extracellular matrix accumulation and metabolic regulation, and the mechanisms involve the NF-kappa B, TGF-beta 1/Smad, PI3K/Akt, p38 MAPK, Nrf2-Nox4, and AMPK signaling pathways. We hope to provide new ideas for pulmonary fibrosis prevention and treatment strategies.

Automated summary

This review summarizes the mechanisms and health benefits of natural products against pulmonary fibrosis, targeting oxidative stress, inflammatory injury, epithelial-mesenchymal transition, fibroblast activation, extracellular matrix accumulation, and metabolic regulation. The mechanisms involve various signaling pathways such as NF-kappa B, TGF-beta 1/Smad, PI3K/Akt, p38 MAPK, Nrf2-Nox4, and AMPK. We aim to provide new ideas for prevention and treatment strategies for pulmonary fibrosis.